Hamilton, Ohio (OH) In Vitro and In Vivo Diagnostic Substances Companies

Featured companies
Phase 2 Discovery Inc
3130 Highland Ave.
Cincinnati OH 45219
(513) 475-6618
Amersham Health Inc
346 Gest St.
Cincinnati OH 45203
(513) 241-5955
Wellpoint
1351 William Howard Taft Road
Cincinnati OH 452061721
(513) 872-8100

Health Insurance Company
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Elite Biosciences
12090 Crestfield Court
Cincinnati OH 45249
(513) 638-9339
Ge Healthcare
346 Gest St.
Cincinnati OH 45203
(513) 241-5955
Meridian Bioscience Inc
3471 River Hills Drive
Cincinnati OH 45244
(513) 271-3700

Meridian Bioscience Inc is a publicly held company in Cincinnati, OH and is a Headquarters business.
Reveal Diagnostics Inc
3130 Highland Avenue Floor 3
Cincinnati OH 45219
(513) 583-5122
Taurus Scientific Inc
8662 Kenwood Road
Cincinnati OH 45242
(513) 984-0097
Phase 2 Discovery Inc
3130 Highland Avenue Floor 3
Cincinnati OH 45219
Petnet Solutions Inc
2139 Alburn Avenue
Cincinnati OH 45219
(865) 218-2000
Whereorg has 14 results under In Vitro and In Vivo Diagnostic Substances Companies in Hamilton.

Narrow down the browsing criteria below to see more companies.

Select a location for category In Vitro and In Vivo Diagnostic Substances


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020